Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

BioSpecifics Technologies Corp. Company Profile (NASDAQ:BSTC)

Consensus Ratings for BioSpecifics Technologies Corp. (NASDAQ:BSTC) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $28.00 (6.10% upside)

Analysts' Ratings History for BioSpecifics Technologies Corp. (NASDAQ:BSTC)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/9/2014MKM PartnersBoost Price TargetBuy$24.50 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
12/9/2013MKM PartnersBoost Price TargetBuy$23.50 -> $24.50ViewTweet This Rating  Share This Rating on StockTwits
11/13/2013MKM PartnersBoost Price TargetBuy$21.00 -> $23.50ViewTweet This Rating  Share This Rating on StockTwits
10/22/2013JMP SecuritiesInitiated CoverageOutperform$28.00ViewTweet This Rating  Share This Rating on StockTwits
5/13/2013MKM PartnersLower Price TargetBuy$21.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2013AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
8/16/2012AegisInitiated CoverageBuy$50.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2012 forward)